This lack of an effect on obesity could well reflect the reduced hepatic 25-hydroxylaton of vitamin D and the increased secretion of FGF-23 secretion seen in obesity—the latter reducing activity of the vitamin D-activating 1-alpha hydroxylase and thus reducing calcitriol formation [100]. The gene discussed is FGF23; the disease is obesity due to melanocortin 4 receptor deficiency.